Cytokines and T lymphocytes in transplantation : targets for immunotherapy
Cytokinen en T lymfocyten in transplantatie: doelen voor immunotherapie
Organ transplantation has become an established therapy in patients suffering from diseases leading to organ failure. Table I shows the number of organ transplants performed in the Eurotransplant area from 1 g90 to 1993. The use of potent immunosuppressive drugs and effective protocols for prevention and treatment of infectious diseases have contributed to improved outcome of clinical organ transplantation. Nowadays, one-year patient and graft survival after kidney transplantation is 85 to 95 % (1). However, the potent immune response to transplanted tissues leading to acute graft rejection remains a major problem.
|Stellingen VOSSEN, Ann Clementina Theodora Maria.pdf , 22kb|
|1082_VOSSEN, Ann Clementina Theodora Maria.jpg Cover Image , 16kb|